Review
Copyright ©The Author(s) 2019.
World J Stem Cells. Apr 26, 2019; 11(4): 212-221
Published online Apr 26, 2019. doi: 10.4252/wjsc.v11.i4.212
Table 1 Indication of autologous hematopoietic stem cell transplantation in autoimmune diseases
IndicationLevel of recommendationLevel of evidence
Systemic sclerosisClinical opportunity: a careful evaluation of the benefit / risk ratio is requiredI
Multiple sclerosisII
Chronic inflammatory demyelinating polyneuropathyII
Myasthenia gravisII
Crohn's diseaseII
Systemic lupus erythematosusII
Rheumatoid arthritisII
Juvenile idiopathic arthritisII
Autoimmune cytopeniasII
Polymyositis/dermatomyositisIII
VasculitidesIII
Neuromyelitis opticaIII
Paraneoplastic neurological symptomsIII
Type 1 diabetes mellitusUnder constructionIII
Refractory celiac diseaseIII